Manufacturing Efficiencies & Cost Savings
Our Imprex SFL Stabilization™ process converts biopharma drugs into room-temperature stable powders that our Licensees can blend,
tabletize, encapsulate, layer into microemulsions and microspheres, or reconstitute into a sterile formulation.
Applied NanoSpheRx technologies give our Licensees extended refrigeration-free inventory life, more flexible production schedules and greater control over manufacturing processes and product-to-market deadlines.
Extensive proof-of-concept research confirms the proprietary Imprex SFL™ Stabilization Process prevents aggregation, preserves and protects conformational structure, and maintains bio-activity.
Custom Imprex SFL® Benefits
- Significantly Reduced Protein/peptide Aggregation and Degradation
- Enhanced bioactivity
- Superior Stability
- Room Temperature Storage
- Precision Sustained-Release
- Improved Patient Compliance
- Extended Shelf-life
The Imprex SFL® Advantage
The Imprex SFL Stabilization Process permits previously unstable protein drug targets to fulfill their therapeutic and financial potential.